SERUM ADALIMUMAB TROUGH LEVELS REQUIRED FOR ENDOSCOPIC MUCOSAL HEALING DURING MAINTENANCE THERAPY OF CROHN'S DISEASE

被引:1
|
作者
Imaeda, Hirotsugu
Nishino, Kyohei
Ohno, Masashi
Nishida, Atsushi
Sugimoto, Mitsushige
Andoh, Akira
机构
关键词
D O I
10.1016/S0016-5085(17)31553-6
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Sa1918
引用
收藏
页码:S393 / S393
页数:1
相关论文
共 50 条
  • [1] Serum adalimumab trough levels required for mucosal healing during Crohn's disease maintenance therapy
    Imaeda, Hirotsugu
    Morita, Yukihiro
    Takahashi, Kenichiro
    Nishida, Atsushi
    Inatomi, Osamu
    Bamba, Shigeki
    Sasaki, Makoto
    Tsujikawa, Tomoyuki
    Sugimoto, Mitsushige
    Andoh, Akira
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 139 - 139
  • [2] Serum adalimumab trough levels required for mucosal healing during maintenance therapy in patients with Crohn's disease
    Imaeda, H.
    Morita, Y.
    Fujimoto, T.
    Takahashi, K.
    Shioya, M.
    Nishida, A.
    Inatomi, O.
    Bamba, S.
    Sasaki, M.
    Tsujikawa, T.
    Sugimoto, M.
    Andoh, A.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S288 - S289
  • [3] Trough levels of adalimumab better correlate with combined mucosal and transmural healing than clinical remission in Korean patients with Crohn's disease on adalimumab maintenance therapy
    Oh, E. H.
    Yoon, A. -R.
    Park, S. H.
    Kim, J.
    Ham, N.
    Song, E. M.
    Hwang, S. W.
    Park, S. H.
    Yang, D. -H.
    Byeon, J. -S.
    Myung, S. -J.
    Yang, S. -K.
    Ye, B. D.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S260 - S261
  • [4] Infliximab Trough Levels Are Associated With Mucosal Healing During Maintenance Treatment With Infliximab in Paediatric Crohn's Disease
    Kang, Ben
    Choi, So Yoon
    Choi, Young Ok
    Lee, Soo-Youn
    Baek, Sun-Young
    Sohn, Insuk
    Choe, Byung-Ho
    Lee, Hae Jeong
    Choe, Yon Ho
    JOURNAL OF CROHNS & COLITIS, 2019, 13 (02): : 189 - 197
  • [5] The Relationship Between Pharmacokinetics of Adalimumab and Mucosal Healing in Patients With Crohn's Disease Maintenance Therapy
    Imaeda, Hirotsugu
    Morita, Yukihiro
    Nishida, Atsushi
    Bamba, Shigeki
    Andoh, Akira
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S847 - S847
  • [6] Accurate Determination of Serum Adalimumab and Anti-Adalimumab Antibodies Levels During Maintenance Therapy for Crohn's Disease
    Imaeda, Hirotsugu
    Takahashi, Kenichiro
    Fujimoto, Takehide
    Bamba, Shigeki
    Sasaki, Masaya
    Tsujikawa, Tomoyuki
    Fujiyama, Yoshihide
    Andoh, Akira
    GASTROENTEROLOGY, 2013, 144 (05) : S431 - S431
  • [7] High Infliximab Trough Levels are Associated With Mucosal Healing in Crohn's Disease
    Van Moerkercke, Wouter
    Ackaert, Chloe
    Compernolle, Griet
    Jurgens, Matthias
    Cleynen, Isabelle
    Van Assche, Gert A.
    Rutgeerts, Paul J.
    Gils, Ann
    Vermeire, Severine
    GASTROENTEROLOGY, 2010, 138 (05) : S60 - S60
  • [8] Higher Adalimumab Drug Levels Are Associated with Mucosal Healing in Patients with Crohn's Disease
    Papamichael, Konstantinos
    Cheifetz, Adam S.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 (05): : 507 - 509
  • [9] Serum infliximab levels and early mucosal healing in Crohn's disease
    Tang, J.
    Gao, X.
    Zhi, M.
    Zhou, H.
    Chen, H.
    Zhang, M.
    Yang, Q.
    Liang, Z.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S209 - S210
  • [10] Influence of Trough Serum Levels and Immunogenicity on Long-term Outcome of Adalimumab Therapy in Crohn's Disease
    Karmiris, Konstantinos
    Paintaud, Gilles
    Noman, Maja
    Magdelaine-Beuzelin, Charlotte
    Ferrante, Marc
    Degenne, Danielle
    Claes, Karolien
    Coopman, Tamara
    Van Schuerbeek, Nele
    Van Assche, Gert
    Vermeire, Severine
    Rutgeerts, Paul
    GASTROENTEROLOGY, 2009, 137 (05) : 1628 - 1640